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Retail Medicine

The “convenient care” movement continues to make national headlines, from CVS’s
acquisition of MinuteClinic to Walgreen’s recent acquisition of Take Care Health Systems.
Developed in response to the need for accessible, affordable, quality healthcare, convenient care
clinics (CCCs) based in retail stores and pharmacies seek to meet the basic health needs of
patients with and without insurance.1 The nurse practitioners (NPs) that primarily staff these
clinics can treat common health problems (eg, strep throat and ear infections), triage patients to
the appropriate level of care, advocate for a medical home for all patients, and reduce unnecessary
visits to emergency rooms and urgent care clinics.1
Because physicians view themselves as the gatekeepers of healthcare, the convenient care
movement has engendered controversy and led to a heterogeneous response from organized
medicine. The American Academy of Pediatrics (AAP), the American Academy of Family
Physicians (AAFP), and the American Medical Association (AMA) have all called for increased
regulation of CCCs. AMA Board of Trustees member William A. Hazel Jr., MD, has stated that
while “store-based health clinics can never replace the patient-physician relationship, with
guidance from the AMA and AAFP they can offer patients a viable option for routine health care
services.”2 However, in its policy statement concerning retail-based clinics, the AAP formally
opposes CCCs as an appropriate source of medical care and discourages their use because of its
commitment to the medical home model and because of concerns regarding fragmentation and
quality of care. Nonetheless, the AAP recognizes that the economics of our current health care
system will support the continued existence of CCCs and has therefore published principles to
guide operations and the quality of care delivered.3 On the other hand, with 400 CCCs in
existence today and an estimated 1,500 operating by the end of next year,4 some physicians have
been trying to introduce legislation to hinder the industry’s ability to grow. An Illinois State
Medical Society-backed Illinois House bill would require CCCs to pay $2,500 for permits from
the state health department, and the ability to obtain these permits includes stipulations such as
having one physician supervisor for every two NPs.4
Unfortunately, these legislative efforts fail to acknowledge the excellent status of NPs in
primary care. Numerous studies, as far back as the 1986 case study released by the Office of
Technology Assessment,5 have found the quality of care provided by NPs and physicians to be
equivalent. Most recently, a descriptive evaluation was conducted at primary care nurse-managed
health centers, where NPs practice independently within a nursing model of primary care, and
population-based measures of quality and healthcare resource utilization were compared to those
of like providers including community health clinics.6 With patients experiencing significantly
fewer emergency room visits, hospital inpatient days, specialist visits, and having a lower risk of
giving birth to low birth weight infants compared to patients in conventional healthcare,6 the
results indicate that nurse-managed health centers reduce healthcare costs through preventive care.1
Given the impending crisis in primary care, we therefore believe it is entirely appropriate to
determine where CCCs fit into the future design of primary care delivery. Currently, the supply
of physicians and nurses is diminishing while the demand for healthcare increases as baby
boomers grow older and develop chronic conditions.7 The CCC service model may efficiently
provide services to a small portion of the population, giving primary care practitioners and
emergency rooms more time for complex cases for which they are appropriately configured.8
Such a model could even improve access to care and create spare capacity for primary care
practices and emergency departments.8
continued p.2

In light of the CCC service model’s ability to influence the
design of future delivery systems, the Department of Health
Policy has taken a keen interest in the growth of the convenient
care industry. One of us (DBN) serves as chairman of the
National Medical Advisory board of Philadelphia-based Take
Care Health Systems, one of the largest retail clinic companies,
and the Department of Health Policy has chaired two meetings
of the advisory board to-date. We also recently produced a
white paper appearing in the April 2007 issue of Disease
Management whose purpose was to describe the entire history of
the convenient care industry, explain the role of NPs in CCCs,
describe the role of the new consumer-driven model of care, and
to identify future directions for the convenient care industry.1
This review of the field was co-authored by Tine Hansen-Turton,
executive director of the newly-formed Convenient Care
Association, a Philadelphia-based national organization
representing CCCs that was founded by healthcare leaders in
October 2006. To further understand this burgeoning industry,
one of us (EJM) also attended the national Retail Health Clinic
Summit in Philadelphia and the national Retail Based Health
Clinic Summit in Chicago earlier this year.
As the industry grows and validates its business model for the
delivery of healthcare, we are particularly interested in its future
research and education agenda. With regard to future directions
for research, a key issue to consider involves the collection of
data on adherence to applicable measures from the Ambulatory
Quality Alliance, the National Committee for Quality Assurance,
or the Centers for Medicare and Medicaid Services’ Physician
Quality Reporting Initiative. These outcomes may further
certify CCCs’ high quality of care due in part to their
standardized protocols and guidelines grounded in evidencebased medicine. For example, emerging evidence suggests that
usage of these protocols by NPs in CCCs to enhance the
decision-making process has led to appropriate testing of, and
antibiotic prescribing to, patients at risk for strep throat.
Meanwhile, recent findings indicate that the major problem of
primary care physicians in the testing and treatment of adults
with sore throats is not which guideline to follow, but that they
usually fail to follow any guideline.9
Moreover, formal collection of data on adherence to national
quality measures leads to the question of whether CCCs should
require an outside quality stamp in order to distinguish the
various chains. Until this happens, CCC chains can differentiate
themselves in the marketplace by publishing quality of care
research in the peer-reviewed literature. Ideally, the entire
industry would follow suit, leading to a commitment to
transparency.
In addition to its future research agenda, the convenient care
industry needs to consider its impact on the medical education
system. CCCs will have to ensure continuity of care by building
effective relationships with local primary care physicians.8 It is
therefore necessary to consider how this model of care delivery
could become a component of the educational process. Questions
then arise, including: should medical school curricula begin to
include medical student training with NPs at these clinics?
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While today’s clinics focus primarily on providing episodic
care, speculation about the future concerns whether they will
become a “disruptive innovation,” a service lacking features of
incumbents that ultimately improves and captures the whole
market.10 CCCs have clearly entered the market at the low end
of medical complexity, and their current service model will
almost certainly not interrupt the core business of primary care
practitioners.8 However, as the industry develops over time,
CCCs may in fact be poised to transmogrify into providers of
chronic care management, with competency in areas such as
core medical and pharmacy management and wellness
management programs. The Department of Health Policy will
continue to pay very close attention to these important issues.
As always, we are interested in your views. You can reach me
at David.Nash@jefferson.edu.
Eric J. Moskowitz
MD/MBA Candidate, 2009
Jefferson Medical College/Widener University
David B. Nash, MD, MBA
Editor
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A Global PHR?
DAVID B. NASH, MD, MBA
probably some early gains in quality. We
Our department was fortunate to receive an
DR. RAYMOND C. AND DORIS N. GRANDON
will have to test this hypothesis in America.
educational grant from InterComponentWare,
PROFESSOR AND CHAIRMAN
AG (ICW), a leading international e-health
Research Redux. There is a paucity of
DEPARTMENT OF HEALTH POLICY
company headquartered in Germany. For the
scholarly peer-reviewed data regarding the
J
EFFERSON MEDICAL COLLEGE
past two years, we have been working with
research agenda for the PHR. How will
the corporate leadership of ICW as they begin to enter the US
we know if we are successful? What are the major outcome
domestic marketplace. ICW “develops and markets software
measures? Can we link a PHR to the Physician Quality
and hardware components for healthcare IT infrastructure for
Reporting Initiative from CMS? Do we really want patients
electronic health cards, personal health record known as
reviewing key laboratory data at home at night while they are
®
LifeSensor and network solutions for clinics and physicians in
online? What if one doctor uses the LifeSensor® web-enabled
private practice.” ICW and its LifeSensor® PHR is the leading
secure password but a referral specialist refuses? How will this
product in Germany, Austria, Switzerland and Bulgaria. With
skew the data and impact the research agenda? The advisory
the help of a nationally prominent advisory board convened by
board grudgingly admitted that we know so little about what
our department, including such domestic luminaries as Janet
really goes on in the black box of an ambulatory primary care visit
Marchibroda from e-Health Initiative and Blackford Middleton
in the United States. Yet, they were heartened to learn that the
from Partners Health Care System, Inc., the goal of our work is
same is probably true in Western Europe!
not only to help ICW to break into the domestic US market, but
Who is the purchaser? The enthusiasm of the advisory board
rather to expand their world view, suggest a research agenda,
was
tempered by a wide-ranging and heartfelt discussion regarding
and network internationally.
who will actually buy LifeSensor®. In the US, will it be large
As we were sailing down the Spree River in the beautiful
employers who essentially give away LifeSensor® as a competitive
reunified city of Berlin this past summer, it struck me that there
recruiting advantage? Will it be managed care plans seeking
were some key take-home lessons that I learned during our
market leverage who fund LifeSensor® and deliver it to a certain
three-day advisory board summit meeting there. I think there
strata of paying customers? Finally, outside of a federal
are at least seven important take-home messages, and I will
government centrally-controlled system it is open to interpretation
articulate each in turn.
as to who the final purchaser might really be. Switzerland, with
Cultural barriers abound! Cultural barriers exist from
9 million people is a nice, neat demonstration project!
both a consumer and physician perspective regarding the use,
Primacy of partners. ICW has done an exemplary job of
connectivity, and penetration of a PHR. For example, in
reaching out to all kinds of partners beyond the German
centrally controlled healthcare systems like Switzerland (with a
Association of Family Practitioners mentioned earlier. They are
total of 9 million inhabitants), ICW has readily made a great
no doubt going to need corporate partners like Intel, Microsoft,
breakthrough in that isolated homogeneous nation. Comparable
or others yet un-named. Maybe they should join with Revolution
breakthroughs in the US market will be rare. German
Health or WebMD to push out LifeSensor® to a broader domestic
physicians were skeptical about the power of a PHR and the
market. Experienced IT professionals in the US know that
additional time it might add to a typical office visit; sound
partnerships come and go just as frequently as corporate mergers
familiar? ICW was smart and worked hand-in-hand with the
and divestitures. Today’s partner is tomorrow’s adversary. A
German Association of Family Practitioners (Deutscher
legacy system that worked yesterday may not connect tomorrow.
Hausaertzeverband) to overcome their reluctance. Dr. Ludwig
It will be important to establish these kinds of partnerships early
Richter helped the domestic advisory board members to grasp
on and to work aggressively to nurture them moving forward.
nuances of the physician cultural barriers, especially in Germany.
Finally, all politics are global! That’s right, not local, global.
Connectivity is king. ICW, like every other healthcare
Our work overseas has convinced me beyond a doubt that a
provider, is struggling to make sure that their product can
PHR and an empowered healthcare consumer is where we need
connect back to any legacy electronic medical record (EMR)
to go. We could quibble over whether it is LifeSensor® or
and hospital-based computerized physician order entry (CPOE)
another outstanding product. But I know in my own practice as
system. It is a real struggle, but because LifeSensor® is entirely
a primary care internist, I relish the day when patients bring an
web-based, everyone believes it can be done. The Germans
easy-to-use, web-enabled, password-protected, no legacy wires
know there is a movement in the US toward standardization.
necessary system to their primary care visit. We could spend
This will go a long way toward the diffusion of the PHR. The
quality time doctoring and get down to what really matters —
real connectivity conundrum will be when a patient with
enhanced doctor-patient communication.
LifeSensor® goes to a primary care doctor who really cannot
Who knows, during my next trip to Germany sometime in
handle the whole idea of an empowered, web-enabled patient.
the future, maybe there really will be a global PHR readily
Connectivity will disconnect at the door in such a practice.
connected, as easily as the internet enables us to do email.
Cashing in on ROI. Whether it is measured in euros, pounds,
Imagine falling ill in Europe and enabling your German primary
or dollars, the language of return on investment is the same. The
care doctor to view all of your domestic records, labs and the
advisory board struggled with the question of how to measure
like. I hope I will get to see this in my practice lifetime.
the return on a PHR. Who will gain? Who will lose? How do
If you would like to learn more about ICW, certainly go to
we measure patient activation? Will empowered patients cost
www.icw-global.com
or www.LifeSensor.com.
the US system more? All the evidence from Germany points to
improved workflow, improved communication all around, and
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Cancer Rehabilitation:
AnPatient
Expanding
Veteran’s Administration
National Center for
Safety Need
Comes to Philadelphia
DEBORAH JULIE FRANKLIN, PHD, MD approach to assessment and intervention
Survival rates for patients with many
different types of cancers have improved
may be efficacious. Implementation,
ASSISTANT PROFESSOR
dramatically over the past few decades. In
however, may be determined by the specific
DEPT. OF REHABILITATION MEDICINE
order to achieve such excellent outcomes
diagnosis and treatment such as the selection
THOMAS JEFFERSON UNIVERSITY
many patients receive aggressive treatment
of transdermal administration of pain
including surgery, chemotherapy and
medication for a head and neck cancer
radiation therapy. Nonetheless their underlying disease
patient with severe dysphagia. Specific tumors are also associated
processes as well as the therapeutic interventions they undergo
with more rapid or indolent progression, which needs to be taken
often create functional deficits that limit quality of life, financial
into account when selecting interventions or rehabilitation goals.
stability and the ability to meet social and family obligations.
Specificity of oncologic diagnosis and staging also determines
These impairments have been shown to persist even in patients
treatment protocols and the resulting side effects and anticipated
whose cancers have been controlled and who are said to be
impairments. Familiarity with the oncologic continuum of care
disease-free.1 Although the relative overall 5-year survival rate
for specific diagnoses is essential for physiatrists committed to
for all cancers now exceeds 65% the “cure” rate remains much
designing optimal rehabilitation programs for cancer patients
lower.2 This means that large numbers of patients require not
and speaks to the importance of having medically trained
just surveillance but repeated oncologic interventions over time,
leadership for cancer rehabilitation programs. Pertinent
interventions that may further impact functional performance.
medical information needs to be disseminated to the entire
interdisciplinary treatment team, ensuring patient safety and
The transformation of cancer from death sentence to chronic
appropriate and realistic support for patients transitioning
disease has made health care practitioners and patients more
through different phases of the disease continuum.
aware of the need to attend to functional and quality-of-life
issues. Rehabilitation medicine specialists have responded by
developing new models of cancer rehabilitation that preserve and
promote function during all phases of disease and treatment.3
Many nationally recognized cancer centers including M. D.
Anderson and Memorial Sloan Kettering, house robust
departments of Physical Medicine and Rehabilitation that
provide clinical services as well as research initiatives.
Cancer rehabilitation services can be effectively introduced in
a variety of institutional settings. They can be initiated through
consultation requests for patients in acute care hospitals, they
can be provided during inpatient rehabilitation stays, and they
can be obtained in outpatient rehabilitation medicine clinics or
by including physiatrists in interdisciplinary clinics organized
around specific diagnoses. Several studies have shown improved
functional outcomes and high levels of patient satisfaction
following rehabilitation interventions in each of these milieus.4,5,6
For example, patients with primary as well as metastatic brain
tumors who participated in an inpatient rehabilitation program
made and maintained gains in Functional Independence
Measure (FIM) scores that matched those made by traditional
rehabilitation candidates.7 Patients with significant disability
from oncologic spinal cord compression have also been shown
to benefit from inpatient rehabilitation.8 Considerable data from
bone marrow transplant units has proven the safety and benefit
of aerobic exercise for this population so convincingly that
exercise protocols are now an expected component of treatment
plans. Specific interventions for lymphedema that develops after
node dissection or speech therapy after laryngectomy are other
examples of the broad range of services that help restore and
maintain function following cancer treatment. Algorithms for
addressing cancer related fatigue (CRF) have been developed by
the National Comprehensive Cancer Network.
A significant challenge to any model for delivering cancer
rehabilitation services results from an ongoing dialectic between
a symptom-based approach and a disease-based approach.
Certain problems including pain; cachexia; fatigue; reduced
range of motion; deficits in activities of daily living; impaired
mobility; or complications from chemotherapy or radiation
occur with many different cancer diagnoses and a standardized
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The Department of Rehabilitation Medicine of Thomas Jefferson
University is currently expanding its cancer rehabilitation
initiative by establishing a dedicated consultation service for
hospitalized patients, developing a specialized program for
inpatient rehabilitation for patients with cancer diagnoses,
pursuing specialized training for physical, occupational, and
speech therapists and offering outpatient evaluations for patients
during and after their treatment for cancer. These services will
help patients maximize the benefits conferred by the state of the
art oncologic treatment they are receiving. In doing so they will
allow us to meet the challenge described by John F. Kennedy in
1963 when he said that “having added new years to life, our
objective must also be to add new life to those years.” 9
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Rx for Pennsylvania: Healing the Healthcare System
Summer Seminar • July 17, 2007
Rx for Pennsylvania: Healing the Health Care System, the
twelfth annual Department of Health Policy Summer Seminar,
was held on the Jefferson campus on July 17, 2007. The keynote
and plenary presentations focused on impending and proposed
changes to Pennsylvania’s health care system, with an emphasis
on the needs of the aging and elderly populations. Following the
presentations, a reactor panel offered impromptu reactions to the
issues raised and the real-world challenges of addressing them.
Secretary Nora Dowd Eisenhower, JD, from the Pennsylvania
Department of Aging, provided context for the morning’s
discussions in the form of demographic trends. Global and
national population projections reveal an impending sea change
in the age 65+ cohort, with its attendant impact on health care
and other services and costs. Because the cost of health care for
this cohort is 3-5 times greater than the cost for those under age
65, the nation’s healthcare spending is projected to increase by
25% by 2030. This upturn in health care needs – to such agerelated issues as multiple chronic conditions, falls, and
depression – will make the shortage of health care providers an
even more acute problem. The key to addressing these
challenges is to proactively determine how best to modify
systems to adapt to the changing demographics.
Rosemary Greco, director of the Governor’s Office on Health
Care Reform, provided an update on the status of the state’s
health care initiatives. Governor Rendell’s goal is to improve the
accessibility, affordability, quality, and cost of health care. The
Rx for Pennsylvania plan addresses these, plus chronic care and
other issues.
Ms Greco briefly outlined the eight health care bills proposed
for this legislative session that were approved late on July 16.
Six of these bills recognize the expansion of scope of practice,
which aligns with the concepts of the Chronic Care Model.
Every clinician now must practice to the fullest extent possible.
One bill concerns Health-Acquired Infection (HAI; formerly
Hospital-Acquired Infection). It is now mandatory that all HAI
be reported, including those occurring in nursing homes and
ambulatory surgery centers. The focus is on transparency and
surveillance (ie, reporting, monitoring, and comparative
analysis). Pennsylvania is the first state to address surveillance.
One bill concerns Assisted Living. This bill defines Assisted
Living and establishes regulations and standards for these
organizations; previously there were none.

the challenges of an aging society. She highlighted state policies
that promote new models of caring for older adults, emphasizing
scope of practice and changes across settings, and stressed the
need to become more creative in the organization and regulation
of health and long-term care.
Robert N. Butler, MD, President and CEO of the International
Longevity Center-USA, delivered the keynote presentation, “The
Longevity Revolution.” Dr Butler discussed the findings of
longevity science, key among which is the need to rethink
diseases in lifespan terms. The foundations of many diseases
considered specific to the elderly were laid much earlier in life.
We must study the biology of aging itself.
Dr Butler also touched on ageism in America, and on the
economic impact of longevity. Health and longevity are
associated with increased wealth. He cited William Nordhaus’
assertion that the value of increased longevity over the 20th
century could be as large as the value of growth in all other
goods and services over the same period.
Dr Butler stressed the need to redesign health care for an older
America. Health care providers, social workers, and caregivers
must be trained in the best techniques for caring for the elderly.
Concurrently, there must be an emphasis on health promotion
and disease prevention, improved chronic disease management,
and enhanced end of life and palliative care. We must work
toward transforming the culture and experience of aging.
A reactor panel of Jefferson colleagues and health care
stakeholders, representing consumers, payors, and practitioners,
offered unscripted responses to queries posed by moderator
David B. Nash, MD, MBA. Among the issues addressed were
the need for: transparency (monetary and care provision),
education (for medical students and consumers), communitybased care, realignment of provider and consumer incentives,
development of advanced career trajectories for health care
workers, and involvement of all stakeholders in solutions. The
thought-provoking comments of the reactor panel and ensuing
dialog with audience members made for stimulating discussion
at the luncheon that followed.
A complete summary of the Summer Seminar presentations
is forthcoming in the December issue of Disease Management.
A podcast of the event is available through a link on the DHP
website at http://www.jefferson.edu/dhp/education_ls.cfm.

Susan Reinhard, PhD, MSN, from the AARP Institute for
Health, Healthcare Policy and Aging, spoke about the changes to
policy and professional norms that must occur in order to meet

New Publications from the Department of Health Policy
Gagne J, Leas B, Lofland JH, Goldfarb NI,
Freitag F, Silberstein S. Quality of care
measures for migraine: a comprehensive
review. Dis Manag. 2007;10 (3):138-146.

Nash DB. Phone Home. Biotechnology
Healthcare. 2007; 4(3)7.
Nash DB. Consumer Engagement. P&T.
2007; 32(5):250.

Pracilio, V. Book Review: The Last Well
Person: How to Stay Well Despite the
Health Care System (Montreal &
Kingston, Canada: McGill-Queen's
University Press; 2004), by Nortin M.
Hadler, MD. Am Journal of Med Qual.
2007; 22:300.
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Chronic Care at the Crossroads

Veteran’s Administration National Center for Patient Safety Comes to Philadelphia
Jefferson’s Department of Health Policy is developing a major
article, “Chronic Care at the Crossroads: Preparing to meet
the challenge of an aging population,” highlighting the key
messages from this important and timely summit. Look for it in
November, 2007 when it will be published as a special supplement
to the December issue of Disease Management. The webcast may
be viewed on-line at http://www.visualwebcaster.com/
event.asp?id=40457.
On July 17, 2007 in Washington, DC, a group of the nation’s
most respected health leaders gathered to discuss and explore
solutions to a highly complex and increasingly urgent challenge for
the US healthcare system – namely, the looming burden of chronic
care for an aging population. This high-level summit, hosted by
Intel Corporation and its Chairman Craig Barrett, was attended
either in person or via web cast by presidents, chairmen and
executive directors of influential organizations including the
National Business Coalition on Health, the National Medical
Association, and Centers for Medicare and Medicaid Services.
Susan Dentzer, PBS’ on-air health correspondent for The
NewsHour with Jim Lehrer, moderated the event which was
modeled on Meet the Press. The summit was organized around
3 expert panels with representation from health care associations,
payors, policy-makers, advocates, providers and provider
organizations, and health technologies.
The first panel discussed the potential impact of the age wave
and chronic disease in the next generation from various perspectives.
Janice Kiecolt-Glaser, PhD (Chair of Medicine, Ohio State
University College of Medicine) shared surprising and disturbing
statistics on the adverse effects of chronic illness on caregivers.
“Caregivers are the second victims.”
Mark B. McClellan, MPA, MD, PhD (Sr. Fellow, AEI Brookings Joint Center for Regulatory Studies, The Brookings
Institution) emphasized the need for a fundamental shift from
“sick care” to “well care,” and for re-alignment of the
reimbursement system. He noted that patients and employers may
be the strongest forces for change.
Suzanne Mintz (President/Co-Founder, National Family
Caregivers Association) sounded a wake-up call, “Not a single
family in America will be untouched by chronic illness.”
Michael L. O’Dell, MD, MSHA, FAAFP (Chair & Director,
Family Medicine Department and Residency Program, North
Mississippi Medical Center) communicated the frustrations of
providers, in particular a funding system that does not support an
essential component of chronic care – coordination.
Craig Barrett (Chairman, Intel Corporation; Board
Member, American Health Information Community) expressed
disappointment in employers who have not taken advantage of the
large amount of readily available health information technology
(eg, personal health records, electronic medical records) that would
improve care and reduce costs.
The second panel shared insights and experiences regarding
current trends (“What is working?”) and challenges (“What
could we be doing better?”) posed by chronic care and the
aging population.
6 September 2007

Steve Agritelley (Director, Product Incubation &
Prototyping, Intel Health Research & Innovation Group)
described almost a decade of Intel social science and ethnographic
research, the insights gained, and the technologies being developed
to affect behavior change.
Tracey Moorhead (President & Chief Executive, Disease
Management Association of America) observed that a transition
is occurring from “sick care” to “wellness” and predicted that
“disease management” will expand to “population management.”
The challenge lies in proving value.
David Lansky, PhD (Senior Director, Health Program &
Executive Director, Personal Health Technology Initiative,
Markle Foundation) noted some successful applications of the
Chronic Care Model and the promise of personal health records
(PHR) as key trends. Challenges include integration of “silos” and
improved outcome measures.
Carmella A. Bocchino, MBA (Executive Vice President,
Clinical Affairs & Strategic Planning, America’s Health
Insurance Plans [AHIP]) discussed the positive impact of current
information technologies on the effectiveness of disease
management programs and the importance of standardized data,
common templates and portability standards for PHR’s.
The third and final panel infused “hope” into the discussion as
they spoke about innovations and possibilities for the future in
meeting the challenges posed by chronic care and aging.
Thomas Lee, MD, MSc (Network President for Partners
Health System & CEO for Partners Community HealthCare,
Boston, MA) predicted a safer, more efficient, better integrated
health care delivery system in five years. New strategies will
address variability at the individual physician level, increased
efficiency through lean management technology, and comprehensive
care designs for complex patients and end-of-life. These initiatives
will require care coordination teams and payment reform.
Larry Minnix (President & CEO, American Association of
Homes and Service for the Aging) described a nation-wide
movement toward “green houses,” a transition that sees care of the
chronically ill and aging taking place in homes or home-like
settings. De-institutionalization of large nursing homes into
smaller, cottage-like settings increases satisfaction among patients
and caregivers.
Carol Raphael, MPA (President & CEO, Visiting Nurse
Service of New York) introduced several high-tech/high-touch
initiatives – eg, a VNSNY program that provides tele-monitors
(programmed in 8 different languages) for 400 heart failure/
hypertension patients. Initial outcomes show a 14% decrease in
hospitalizations and a 12% decrease in emergency room visits.
Mariah Scott, MBA (General Manager, Intel Personal
Health Platforms) introduced the concept of using technology for
decision support (for providers, patients and their caregivers) and
for sustaining behavior change.
Allen Woolf, MD (Sr. Vice President & National Medical
Officer, Health Advocacy, CIGNA Healthcare) described new
inroads being forged by health coaches who equip people with
information, technology and skills to modify behavior and to help
sustain healthy behavior.

Accelerating
Care
Pennsylvania
Veteran’s Administration
NationalBest
Center
for in
Patient
Safety Comes to Philadelphia
VALERIE PRACILIO
Improving health care in Pennsylvania is a
in their own institution. The February
PROJECT MANAGER FOR
priority for governmental officials and health
session laid the groundwork for the
QUALITY IMPROVEMENT
care providers. This was demonstrated
projects that the teams were to complete
D
EPARTMENT
OF HEALTH POLICY
through the collaborative efforts of Thomas
by the end of the program.
JEFFERSON MEDICAL COLLEGE
Jefferson University’s Department of Health
The team from Hazleton General
Policy and Baylor Health Care System in
Hospital chose to focus their efforts on the
Dallas, Texas who set out to “Accelerate Best Care in
administration of heart failure discharge instructions; surgical
Pennsylvania” (ABC in PA) in January of 2007. The
antibiotic prophylaxis; pneumococcal vaccinations; stroke care;
organizations were given support via a state grant through
and pneumonia care. The Meadville Medical Center team
the efforts of Representative Todd A. Eachus, Democratic
focused on pneumococcal vaccination administration and DVT
Majority Policy Chair, 116th Legislative District. The goal of
prophylaxis. After months of rigorous training and diligent
ABC in PA was to collaboratively identify health care needs,
work, team members presented the results of their efforts June 7,
set targets and demonstrate quality improvement for rural
2007 in Harrisburg, in front of Representative Eachus and
hospitals in Pennsylvania. Two community hospitals were
stakeholders from across the state. Hazleton reached their
chosen to participate: Hazleton General Hospital, a 127 bed
goal of increased compliance for each of the initiatives they
not-for-profit institution in Hazleton, Pennsylvania and
implemented and moved one step closer to earning the
Meadville Medical Center, a 248 bed not-for-profit institution
designation of Stroke Center of Excellence. Meadville also
in Meadville, Pennsylvania.
demonstrated marked improvements by achieving 100%
A team of individuals from different disciplines within the
hospital were identified and met in Hershey, PA in January of
2007 for the first of three sessions to learn about continuous
quality improvement. In January, the participants learned about
the structure, process and outcomes of improving quality. Each
of the teams received coaching from the Jefferson and Baylor
teams and was advised on how to effectively implement change

compliance on administration of pneumococcal vaccinations
and DVT prophylaxis, and enjoyed significant financial gains.
The team’s efforts helped to set the standard for “Accelerating
Best Care” in rural hospitals throughout Pennsylvania. For more
information about Accelerating Best Care in Pennsylvania,
please contact me at valerie.pracilio@jefferson.edu.
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Veteran’s Administration National Center for Patient Safety Comes to Philadelphia
Annual Fellows Day: A Welcoming Reunion
June 11, 2007
The Department of Health Policy has mentored Outcomes
Research Fellows for more than 10 years. It has become a
tradition for the Department to host an annual reunion of the
group each spring. Fellows Day offers current first year
Fellows the opportunity to showcase their work, and
graduating Fellows a chance to celebrate their completion of
the program. This half-day event welcomes both current and
alumni Fellows, Senior Scholars, and invited guests from the
pharmaceutical companies that sponsor our fellowship
programs.
At this year’s event, first year fellow Seina P Lee, PharmD,
MS and MD/MBA students, Jeffrey Clough (2008) and Eric
Moskowitz (2009) each presented a research project.
Seina P. Lee, PharmD, MS
Ortho-McNeil Janssen Outcomes Research Fellow (2006-2008)
Seina P. Lee presented results from a research project on the
impact of appropriate pharmaceutical care on heart failure
outcomes in the Medicare population. This retrospective study
used a large observational survey, the Medicare Current
Beneficiary Survey (MCBS) Cost and Use file, to evaluate the
relationship between utilization and recommended medications
and disease-related outcomes, such as hospitalization, costs and
mortality. The preliminary findings of the study suggest that
only 50 percent of patients with heart failure (HF) receive
recommended therapy for HF management. Patients who are
not on appropriate medication appear to have worse clinical
and non-clinical outcomes, including higher hospitalization
rate, increased mortality rate and higher costs.
Jeffrey Clough
MD/MBA Candidate 2008
Jeff Clough reviewed results from a study examining the
impact of appropriate medication therapy for several chronic
diseases on medical and productivity costs from the employer
perspective. The study found that for several conditions,
savings in terms of reduced future medical expenditures and
increased productivity more than compensated for the initial
cost of treatment. However, there is still a paucity of validated
measures for determining the costs of chronic diseases to
accurately quantify these savings. This is particularly true
with presenteeism, or reduced productivity at work, which
represents the bulk of costs related to some conditions.

Eric Moskowitz
MD/MBA Candidate 2009
Eric Moskowitz discussed key themes from a qualitative
study of medical and pharmacy benefit design for specialty
pharmaceuticals. Eleven telephone interviews with health care
purchasers and policy experts revealed that benefit design for
specialty pharmaceuticals is a challenge for payors and
insurers, and no clear trends in how payors and insurers
manage these drugs are evident. Practices and policies vary
according to the organization and the nature of the drug and its
alternatives; and there is fragmentation between drugs
reimbursed through the medical benefit versus the pharmacy
benefit. Furthermore, insurers need more data to demonstrate
the value of these products in terms of improved outcomes.
Overall, the ability to provide better care for patients taking
these specialty products requires better integration between the
medical and pharmacy benefit.

Following the presentations, a panel of five alumni Fellows
were invited to share insight into their past Fellowship
experiences, current role and responsibilities, career development
and, most importantly, offer ideas and advice regarding
professional career opportunities. The live interactive panel
discussion allowed former Fellows to present their views on
the future trends and what they believe will influence the
future of outcomes research. Panelists included:
Vijay Nadipelli, PharmD, MS (1995-1997)
Associate Director
Health Economics, Outcomes and Reimbursement
Bayer Healthcare Pharmaceuticals
Joseph Doyle, RPh, MBA
Director
Health Economics and Outcomes
Research-Employer Group
Mike Schaffer, PharmD, MBA (1997-1999)
President/CEO
Medicents
Julie C Locklear, PharmD, MBA (1998-2000)
Value Demonstrator Leader
Health Economics and Outcomes Research
AstraZeneca Pharmaceuticals
Chureen Carter, PharmD, MS (2001-2003)
Regional Outcomes Research Manager
Ortho Biotech Clinical Affairs, LLC
The Department presented recognition certificates to alumni
who completed the Fellowship training more than 10 years
ago. Fellowship Director Vittorio Maio, PharmD, MSPH, MS,
presented graduation certificates to the three graduating
Fellows (Joshua Gagne, PharmD, Madhu Singh, MD, and
Amy Talati, PharmD) in recognition of their completion of
two years of rigorous training.
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Health Policy Forums
Revolution Health Group Clinical Strategies
Jeff Gruen, MD, MBA
Chief Medical Officer
Revolution Health Group
June 13, 2007
Nowhere is the movement of consumerism in health care more
obvious than the myriad of medical websites offering a broad
range of information and services. Revolution Health Group is a
relatively new consumer-centric health company whose primary
service is a free online medical resource center designed to help
consumers manage their health needs. Grounded in evidencebased medicine, Revolution Health emphasizes consumer
empowerment, informed decision-making and personalized care.
The board and staff of Revolution Health represent an
impressive cross-disciplinary team whose expertise includes
consumer marketing, healthcare, and information technology.
Jeff Gruen, MD, MBA, Chief Medical Officer of Revolution
Health Group, explained how the notion of consumerism was the
driving force behind the development of this innovative
company. Consumerism, in general, fits within the trend of the
current world economy and the changing nature of work.

Healthcare mimics other industries, and change can occur if
tools and strategies are changed, and consumers are galvanized.
Gruen described how consumers are not engaged and may even
be actively disengaged in their care. Often, consumers feel what
Gruen identifies as “superficial attention.” Gruen asks that we
think about the connectedness that an individual needs to feel
this need, which is essential in any healthcare encounter. Related to
this, providers have the opportunity to look at consumer
dissatisfaction and create opportunities to become re-enfranchised.
Revolution Health identifies women between the ages of 3055 as the critical consumer audience to reach in accessing services
and implementing change. Recently, Revolution Health teamed
with Columbia University Medical Center to launch a new internet
destination for maternal fetal health. Faculty of the Columbia
OB/GYN department function as an expert resource in providing
content and identifying ongoing information related to maternal
health. Additionally, the faculty will participate in weekly blogs
to assist women in understanding information and new choices
affected by the advances in maternal fetal health technology.
To learn more about the Revolution Health Group visit:
http://www.revolutionhealth.com/.
To access a podcast of the Revolution Health Group meeting
visit: http://www.jefferson.edu/dhp/education_pp.cfm.

HEALTH POLICY FORUM: FALL 2007
The Forum meets on the second Wednesday of each month (September-June) from 8:30 a.m. to 9:30 a.m.
in Conference Room 218, Curtis Building, 1015 Walnut Street, Philadelphia, PA. A light breakfast will be served.
September 12, 2007
Household Survey and Consumer Driven Health Care
Cindy Fillman
Director, Office of Consumer Liaison
Commonwealth of Pennsylvania

November 7, 2007
Medication Therapy
Management and Pharmacy Quality Measurement
Dave Domann, MS, RPh
Senior Director, Healthcare Quality Management
Ortho-McNeil Janssen Scientific Affairs, LLC

October 10, 2007
Pharmaceutical Management Program & Business
Strategy with Science and Technology
Kevin Caviston
Director, Drexel MBA Pharmaceutical Management
Drexel University

December 12, 2007
PA Budget and Healthcare
Lawrence M. Clark, Esq
Director of Legislative Affairs
Governor’s Office of Healthcare Reform
Commonwealth of PA

Department of Health Policy Presentations
Sarfaty, M. Practical
Solutions to Increasing
Screening. Dialogue for
Action™ to Increase
Colorectal Cancer
Screening in New
Jersey. June 28, 2007,
Trenton, NJ.
10 September 2007

Sarfaty, M.
Dissemination of the
Outpatient Improvement
Message. The National
Colorectal Cancer
Roundtable (NCCRT),
Colorectal Cancer
Clinicians’ Guide One
Day Forum, June 29,
2007, Washington, DC.

Safarty, M. Screening
for Colorectal Cancer.
Warren County Medical
Society, July 13, 2007,
Warren, PA.

Yuen, EJ. Meditation
and Healthy Aging.
Complementary and
Alternative Medicine for
Elders. Eastern
Pennsylvania Geriatrics
Society, March 22,
2007, Conshohocken,
PA.

Yuen, EJ.
Understanding Culture
and Diversity: Shaping
the Face of Grief.
WHYY Wider
Horizons: Living With
Grief: Before and After
Death, March 22, 2007,
Philadelphia, PA.
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